Subscribe Now Subscribe Today
Research Article
 

Antibacterial Effects of Iranian Fennel Essential Oil on Isolates of Acinetobacter baumannii



N.H. Jazani, M. Zartoshti, H. Babazadeh, N. Ali-daiee, S. Zarrin and S. Hosseini
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

The aim of the present study was the evaluation of the antibacterial activity of Fennel essential oil on isolates of Acinetobacter baumannii. Forty eight isolates were collected from clinical specimens from burn wards of hospitals in Tehran, Iran between April and September, 2006. The susceptibility of isolates was determined using a broth microdilution method. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of isolates to Fennel essential oil were determined. The susceptibilities of isolates to different antibiotics were tested using agar disk diffusion method. The rates of resistance were determined to antibiotics as follows: cefazolin 100%, ciprofloxacin 100%, ofloxacin 95.8%, kanamycin 95.8%, carbenicillin 93.7%, ticarcillin 93.7%, piperacillin 88.9%, co-trimoxazole 79.1%, ceftizoxime 75%, gentamicin 70.8%, cefalotin 60.4%, amikacin 52% and imipenem 14.6%. Fennel essential oil possessed antibacterial effect against all isolates of A. baumannii. These results suggest the potential use of the Fennel essential oil for the control of multi-drug resistant A. baumannii infections. However, more adequate studies must be carried out to verify the possibility of using it for fighting bacterial infections in human.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

N.H. Jazani, M. Zartoshti, H. Babazadeh, N. Ali-daiee, S. Zarrin and S. Hosseini, 2009. Antibacterial Effects of Iranian Fennel Essential Oil on Isolates of Acinetobacter baumannii. Pakistan Journal of Biological Sciences, 12: 738-741.

DOI: 10.3923/pjbs.2009.738.741

URL: https://scialert.net/abstract/?doi=pjbs.2009.738.741
 

INTRODUCTION

Medicinal plants contain biologically activity compounds, many of which have been shown to have antibacterial properties (Mohsenzadeh, 2007). Foeniculum vulgare (Fennel) belonging to the family Apiaceae is a perennial herb native to the Mediterranean Region. It is widely cultivated and extensively used as a culinary spice. The plant is aromatic and is used as a pot herb. The leaves have diuretic properties and the roots are regarded as purgatives. Dried fruits of Fennel possess a pleasant aromatic taste and used for flavouring soups, meat dishes and sauces. The fruits are considered to be useful in treatment of diseases of the chest, spleen and kidney (Singh and Kale, 2008).

The antiinflammatory, analgesic and antioxidant activities of the fruit of Fennel have been reported previously by Choi and Hwang (2004). Oral administration exhibited inhibitory effect against acute and subacute inflammatory diseases and type IV allergic reactions and showed a central analgesic effect. It significantly decreased the high density lipoprotein-cholesterol level along with a decrease in the peroxidative damage (Choi and Hwang, 2004). The antibacterial activity of essential oil of Fennel has been reported previously by Ruberto et al. (2000).

Anethole is the principal active component of Fennel seeds which has exhibited anticancer activity (Aggarwal et al., 2008). Also, chemopreventive potential of Fennel against carcinogenesis has been shown earlier by Singh and Kale (2008).

Acinetobacter baumannii is a Gram-negative, nonmotile, nonfermentative and oxidase-negative bacillus, whose natural reservoir has not been clearly determined. It is found in many hospital environments and can be colonize in human body in the hospital environments. The combination of its environmental colonization and its very high resistance to antimicrobial renders it as a successful nosocomial pathogen (Nordmann, 2004). There are many reports of Multi Drug Resistant (MDR) A. baumannii from hospitals in Europe, North America, Argentina, Brazil, China, Taiwan, Hong Kong, Japan and Korea and many other areas (Barbolla et al., 2003; Houang et al., 2001; Lee et al., 2004; Liu et al., 2006; Naas et al., 2006; Nishio et al., 2004; Quale et al., 2003; Van Looveren and Goossens, 2004; Yu et al., 2004). These MDR strains often spread to cause outbreaks throughout hospital wards. Acinetobacter sp. is usually considered to be opportunistic pathogens. They cause a wide range of clinical complications, such as pneumonia, septicemia, urinary tract infection, wound infection and meningitis, especially in immunocompromised patients. MDR A. baumannii infections tend to occur in immunosuppressed patients, in patients admitted in intensive care and burn units and in those subjected to invasive procedures and treated with antibiotics. In respect of its very high resistance to antimicrobials, introducing of the new antimicrobial agents against this bacterium is one of the most important goals in treatment of such infections (Perez et al., 2007).

In this study we evaluated the antibacterial activity of Fennel on 48 hospital isolates of MDR A. baumannii.

MATERIALS AND METHODS

Essential oil: Fennel essential oil from Barije Essence Pharmaceutical Company, Iran (commercial producer of plant essential oils and aromatic substances) were used in this study. The oil was selected based on literature survey and its use in traditional medicine. Quality of the oil ascertained to be more than 80% pure. The main effective components of the Fennel essential oil were anethole (50-60%) and fenchone (10-20%).

Bacterial strains and culture media: A total of 48 isolates were collected from clinical specimens from burn wards of hospitals in Tehran, Iran during a 6 months period between April and September, 2006. The isolates were further processed by the standard methods to identify as the A. baumannii (Baron and Finegold, 1990). Isolated bacteria were maintained for long storage on skimmed milk medium (BBL) by adding 10% glycerol in -60°C, cultures were maintained for daily use on nutrient agar (BBL) slants at 4°C. The Muller Hinton Agar (MHA) and Muller Hinton Broth (MHB) medium (Pronadisa) were used for detection of antibiotic resistance of strains. Acinetobacter calcuaceticus PTCC 1318 has been used as reference strain.

Determination of antimicrobial activity of Fennel essential oil: The susceptibility of Acinetobacter isolates to Fennel essential oil was determined using a broth microdilution method based on CLSI guidelines. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Fennel essential oil for isolates were determined. Muller-Hinton Broth (MHB; Oxoid) was supplemented with 0.002% (v/v) Tween 80 (Sigma) (MHB-T) to enhance dispersion of the Fennel oil (Papadopoulos et al., 2006). The initial concentration of Fennel essential oil in the first tube contains MHB-T was ½.

This was used to prepare serial doubling dilutions over the range 0.03-25% (v/v). 1.5x106 inoculums of the isolates were added to each concentration in MHB-T. A tube containing growth medium without essential oil and an un-inoculated tube were used as a positive and negative growth control, respectively. Antibacterial activity was measured by determining MICs and MBCs. The MIC was the lowest concentration of essential oil that resulted in a clear tube. Ten microlitres from each tube was spot-inoculated onto Nutrient Agar (NA) and incubated overnight at 37°C to determine the MBC. The highest dilution that inhibits bacterial growth on nutrient agar after overnight incubation was taken as MBC (Baron and Finegold, 1990; Papadopoulos et al., 2006). Experiments were repeated for three times and the modal value calculated.

Determination of the strains sensitivity to antibiotics: The susceptibilities of isolates to different antibiotics were tested using agar disk diffusion method. To represents the different classes of antimicrobial agents commonly used for the treatment of Acinetobacter sp. infections, we used piperacillin, ciprofloxacin, gentamicin, ofloxacin, cephalotin, ticarcillin, kanamycin, imipenem, amikacin, co-trimoxazole, ceftizoxime, cefazolin and carbenicillin (Hi-media, Mumbai, India).

RESULTS

The rates of resistance to different antibiotics for 48 isolates of Acinetobacter baumannii have been shown in Table 1. Cefazolin (100%), ciprofloxacin (100%) ofloxacin (95.8%) and kanamycin (95.8%) showed the highest rate of resistance and amikacin (52%) and imipenem (14.6%) demonstrated the lowest (Table 1). 45.8% of isolates showed resistance to the 11 tested antimicrobials. Results showed that Fennel essential oil possessed antibacterial effect against all isolates of Acinetobacter sp. (Table 2), 39 isolate were sensitive to all tested dilutions and the remaining nine isolates showed MIC and MBC values in the range of 3.9x10-3 to 1.56x10-2 mm3 mm-3 (Table 2).

Table 1: The rates of resistance to different antibiotics for 48 burn wound isolates of Acinetobacter baumannii

Table 2: Antibacterial activity of Fennel essential oil against 48 burn isolates of Acinetobacter baumannii

Also Acinetobacter baumannii PTCC1318 was sensitive to all tested dilutions.

There was complete growth on the positive growth control tube (containing growth medium without essential oil) and no growth on negative growth control (un-inoculated tube).

DISCUSSION

Acinetobacter baumannii play an important role in colonization and infection of patients admitted to hospitals. They have been implicated in a variety of hospital acquired infections, including bacteremia, urinary tract infection, meningitis and pneumonia (Perez et al., 2007). Antibiotic resistance is a major problem in treating infection with A. baumannii, which has become resistant to almost all available antibacterial drugs (Longo et al., 2007). The use of broad spectrum antibiotics in hospital environments for treating such infections results in promoting infections by multi-antibiotic resistant isolates. Present finding showed that the most useful antibiotics for infections caused by A. baumannii were imipenem, amikacin and cefalotin. Resistance to some antibiotics such as gentamicin, ciprofloxacin and co-trimoxazole showed very high increases in comparison with earlier studies by Guardabassi et al. (1998). Also, in present study burn wound isolates of Acinetobacter baumannii showed high resistance to other tested antibiotics (Table 1), so it seems reasonable to explore new sources of natural compounds with antibacterial activity against Acinetonacter sp.

The antimicrobial properties of essential oils obtained from Foeniculum vulgare have been investigated in different trails. The oil has been shown to be effective against Streptococcus haemolyticus, Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli, Klebsiella species, Staphylococcus epidermidis (Mohsenzadeh, 2007), Bacillus cereus and Bacillus brevis (Ozcan et al., 2006). Another study has shown an activity against the food-borne pathogens like Escherichia coli O157:H7, Listeria monocytogenes, Salmonella typhimurium and Staphylococcus aureus but in Sagdic’s study Fennel extract was inactive against some pathogenic bacteria (Sagdic and Yasar, 2005).

In present study results showed that Fennel essential oil possessed antibacterial effect against all isolates of Acinetobacter baumannii, furthermore, beside the confirmation of the popular use, the obtained results demonstrate that this herbal drug could represent a new source of antimicrobial agents, for the control of Acinetobacter infections. However, more adequate studies must be carried out to verify the possibility of using it for fighting these bacteria in human body infections.

ACKNOWLEDGMENT

This study has been supported by a research grant from student research committee of Urmia University of Medical Sciences.

REFERENCES
1:  Aggarwal, B.B., A.B. Kunnumakkara, K.B. Harikumar, S.T. Tharakan, B. Sung and P. Anand, 2008. Potential of spice-derived phytochemicals for cancer prevention. Planta Med., 74: 1560-1569.
CrossRef  |  PubMed  |  Direct Link  |  

2:  Barbolla, R.E., D. Centron, A. Di-Martino, S. Maimone and C. Salgueira et al., 2003. Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City. Diagn. Microbiol. Infect. Dis., 45: 261-264.
PubMed  |  

3:  Baron, E.J. and S.M. Finegold, 1990. Bailey and Scott's Diagnostic Microbiology. 8th Edn., CV Mosby Co., St. Louis, USA., pp: 286-402, 435-438.

4:  Choi, E.M. and J.K. Hwang, 2004. Antiinflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia, 75: 557-565.
PubMed  |  

5:  Guardabassi, L., A. Petersen, J.E. Olsen and A. Dalsgaard, 1998. Antibiotic resistance in Acinetobacter spp. isolated from sewers receiving waste effluent from a hospital and a pharmaceutical plant. Applied Environ. Microbiol., 64: 3499-3502.
PubMed  |  

6:  Houang, E.T., Y.W. Chu, C.M. Leung, K.Y. Chu, J. Berlau, K.C. Ng and A.F. Cheng, 2001. Epidemiology and infection control implications of Acinetobacter sp. in Hong Kong. J. Clin. Microbiol., 39: 228-234.
CrossRef  |  PubMed  |  

7:  Lee, S.O., NJ. Kim, S.H. Choi, T. Hyong-Kim and J.W. Chung et al., 2004. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: A case-control study. Antimicrob. Agents Chemother., 48: 224-228.
PubMed  |  

8:  Liu, S.Y., J.Y. Lin, C. Chu, L.H. Su, T.Y. Lin and C.H. Chiu, 2006. Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan. Int. J. Antimicrob. Agents, 27: 81-84.
PubMed  |  

9:  Longo, B., A. Pantosti, I. Luzzi, A. Tarasi and F. Di Sora et al., 2007. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit. Ann. Ist Super Sanita, 43: 83-88.
PubMed  |  

10:  Mohsenzadeh, M., 2007. Evaluation of antibacterial activity of selected Iranian essential oils against Staphylococcus aureus and Escherichia coli in nutrient broth medium. Pak. J. Biol. Sci., 10: 3693-3697.
CrossRef  |  PubMed  |  Direct Link  |  

11:  Naas, T., P. Bogaerts, C. Bauraing, Y. Degheldre, Y. Glupczynski and P. Nordmann, 2006. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother., 58: 178-182.
PubMed  |  

12:  Nishio, H., M. Komatsu, N. Shibata, K. Shimakawa and N. Sueyoshi et al., 2004. Metallo-β-lactamase-producing gram-negative bacilli: Laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J. Clin. Microbiol., 42: 5256-5263.
PubMed  |  

13:  Nordmann, P., 2004. Acinetobacter baumannii, the nosocomial pathogen par excellence. Pathol. Biol., 52: 301-303.
PubMed  |  

14:  Ozcan, M.M., O. Sagdic and G. Ozkan, 2006. Inhibitory effects of spice essential oils on the growth of Bacillus species. J. Med. Food, 9: 418-421.
PubMed  |  

15:  Papadopoulos, C.J., C.F. Carson, K.A. Hammer and T.V. Riley, 2006. Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components. J. Antimicrob. Chemother., 58: 449-451.
Direct Link  |  

16:  Perez, F., A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather and R.A. Bonomo, 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 51: 3471-3484.
CrossRef  |  PubMed  |  

17:  Quale, J., S. Bratu, D. Landman and R. Heddurshetti, 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis., 37: 214-220.
PubMed  |  

18:  Ruberto, G., M.T. Baratta, S.G. Deans and H.J.D. Dorman, 2000. Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils. Planta Med., 66: 687-693.
CrossRef  |  PubMed  |  Direct Link  |  

19:  Sagdic, O. and A.N.K. Yasar, 2005. Antibacterial effects of single or combined plant extracts. Ann. Microbiol., 55: 67-71.

20:  Singh, B. and R.K. Kale, 2008. Chemomodulatory action of Foeniculum vulgare (Fennel) on skin and forestomach papillomagenesis, enzymes associated with xenobiotic metabolism and antioxidant status in murine model system. Food Chem. Toxicol., 46: 3842-3850.
PubMed  |  

21:  Van Looveren, M. and H. Goossens, 2004. Antimicrobial resistance of Acinetobacter sp. in Europe. Clin. Microbiol. Infect., 10: 684-704.
CrossRef  |  PubMed  |  

22:  Yu, Y.S., Q. Yang, X.W. Xu, H.S. Kong, G.Y. Xu and B.Y. Zhong, 2004. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J. Med. Microbiol., 53: 653-656.
PubMed  |  

©  2021 Science Alert. All Rights Reserved